Wednesday, September 26, 2018

ACEA Biosciences Acquired by Agilent

San Diego-based ACEA Biosciences, a developer of analytical instruments, systems, and software used in the biotech and pharmaceutical industries, along with academia, has been acquired by Agilent Technologies. Financial details of the acquisition were not announced. According to the companies, the acquisition will help Agilent expand its team and broaden its portfolio of technology. ACEA's products, which include a line of benchtop flow cytometry systems, are used in the immuno-oncology, pre-clinical drug discovery and development, and basic academic research. ACEA's CEO is Xiao Xu.

---